Results 41 to 50 of about 4,409,099 (306)

In silico design of a multi-epitope vaccine against HPV16/18

open access: yesBMC Bioinformatics, 2022
Abstract Background Cervical cancer is the fourth most common cancer affecting women and is caused by human Papillomavirus (HPV) infections that are sexually transmitted. There are currently commercially available prophylactic vaccines that have been shown to protect vaccinated individuals against HPV infections, however,
Samira Sanami   +9 more
openaire   +4 more sources

Immunoinformatics-Aided Analysis of RSV Fusion and Attachment Glycoproteins to Design a Potent Multi-Epitope Vaccine

open access: yes, 2022
Respiratory syncytial virus (RSV) usually causes respiratory tract infections of upper airways in infants and young children. Despite recent medical advances, no approved vaccine is available to control RSV infections.
Shahkaar Aziz   +7 more
core   +1 more source

Design of immunogenic and effective multi-epitope DNA vaccines for melanoma [PDF]

open access: yesCancer Immunology, Immunotherapy, 2011
Plasmid DNA vaccination is an attractive way to elicit T cell responses against infectious agents and tumor cells. DNA constructs can be designed to contain multiple T cell epitopes to generate a diverse immune response to incorporate numerous antigens and to reduce limitations due to MHC restriction into a single entity.
Hyun-Il, Cho, Esteban, Celis
openaire   +2 more sources

Designing a Multi-Epitope Subunit Vaccine against VP1 Major Coat Protein of JC Polyomavirus

open access: yes, 2023
The JC polyomavirus virus (JCPyV) affects more than 80% of the human population in their early life stage. It mainly affects immunocompromised individuals where virus replication in oligodendrocytes and astrocytes may lead to fatal progressive multifocal
Pandey, RK   +11 more
core   +1 more source

RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. [PDF]

open access: yes, 2006
OBJECTIVE: The candidate malaria vaccine RTS,S/AS02A is a recombinant protein containing part of the circumsporozoite protein (CSP) sequence of Plasmodium falciparum, linked to the hepatitis B surface antigen and formulated in the proprietary adjuvant ...
Dobaño, Carlota, 1969-   +37 more
core   +1 more source

Additional file 6 of Designing a novel multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Enterococcus faecium bacterium

open access: yes, 2022
Additional file 6: Table S6.
Jyotirmayee Dey (11359419)   +8 more
core   +1 more source

Design and validation of a novel multi-epitopes vaccine against hantavirus

open access: yesJournal of Biomolecular Structure and Dynamics, 2023
Hantavirus is a member of the order Bunyavirales and an emerging global pathogen. Hantavirus infections have affected millions of people globally based on available epidemiological data and research studies. Hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) are the two main human diseases associated with hantavirus ...
Taghreed N. Almanaa   +8 more
openaire   +2 more sources

Immunoinformatics Approach to Design a Multi-Epitope Vaccine against Cutaneous Leishmaniasis

open access: yes, 2023
Cutaneous Leishmaniasis (CL), a neglected vector-borne disease caused by protozoan parasite Leishmania major (L. major), is a major public health concern, and the development of new strategies to reduce the disease incidence has become a top priority ...
Esra Atalay Şahar   +13 more
core   +1 more source

Design of a multi-epitope vaccine candidate against Brucella melitensis

open access: yesScientific Reports, 2022
Abstract Brucella is a typical facultative intracellular bacterium that can cause zoonotic infections. For Brucella, it is difficult to eliminate with current medical treatment. Therefore, a multi-epitope vaccine (MEV) should be designed to prevent Brucella infection.
Min Li   +9 more
openaire   +3 more sources

DataSheet_1_Computational Design of a Multi-Epitope Vaccine Against Porphyromonas gingivalis.docx

open access: yes, 2022
Porphyromonas gingivalis is a Gram-negative pathogenic bacterium associated with chronic periodontitis. The development of a chimeric peptide-based vaccine targeting this pathogen could be highly beneficial in preventing oral bone loss as well as other ...
Sajjad Ahmad (768814)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy